David H. Henry

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

David H. Henry, Luís Costa, François Goldwasser et al. · Journal of Clinical Oncology · 2011 · 1.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.

David H. Henry, Hema N. Viswanathan, Eric P. Elkin et al. · Supportive Care in Cancer · 2008 · 387 citations

Medicine, Oncology, Cancer Epidemiology +13

Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study

Giorgio V. Scagliotti, Vera Hirsh, Salvatore Siena et al. · Journal of Thoracic Oncology · 2012 · 340 citations · Full text

Medicine, Oncology, Metastasis +16

Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy

David H. Henry, Naomi V. Dahl, Michael Auerbach et al. · The Oncologist · 2007 · 268 citations · Full text

Medicine, Hematology, Pharmacology +17

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Joseph A. Sparano, Jeannette Y. Lee, Lawrence D. Kaplan et al. · Blood · 2009 · 256 citations · Full text

Medicine, Oncology, Pharmacology +8